Amundi
IRWD icon

Amundi’s Ironwood Pharmaceuticals IRWD Stock Holding History

Amundi’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
32,991
-371,246
-92% -$1.43M ﹤0.01% 2008
2026
Q1 		$1.42M Sell
404,237
-238,593
-37% -$978K ﹤0.01% 1183
2025
Q4 		$2.17M Buy
+642,830
New +$1.67M ﹤0.01% 1149
2025
Q3 		– Sell
-755,536
Closed -$559K – 1635
2025
Q2 		$559K Buy
755,536
+685,556
+980% +$538K ﹤0.01% 1348
2025
Q1 		$95.2K Buy
69,980
+8,001
+13% +$19.1K ﹤0.01% 1754
2024
Q4 		$284K Buy
61,979
+38,889
+168% +$158K ﹤0.01% 1671
2024
Q3 		$95.8K Buy
23,090
+2,381
+11% +$12.8K ﹤0.01% 1776
2024
Q2 		$127K Sell
20,709
-3,380
-14% -$23.9K ﹤0.01% 1674
2024
Q1 		$183K Buy
24,089
+5,197
+28% +$63.1K ﹤0.01% 1652
2023
Q4 		$236K Buy
18,892
+1,600
+9% +$15.8K ﹤0.01% 1592
2023
Q3 		$162K Sell
17,292
-53
-0.3% -$519 ﹤0.01% 1648
2023
Q2 		$180K Buy
17,345
+15,502
+841% +$167K ﹤0.01% 1627
2023
Q1 		$19.4K Hold
1,843
– – ﹤0.01% 1963
2022
Q4 		$20.7K Sell
1,843
-335,157
-99% -$3.8M ﹤0.01% 1793
2022
Q3 		$3.53M Buy
+337,000
New +$3.82M ﹤0.01% 1041

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Amundi's IRWD Position: Q2 2026 in Review

Amundi reduced its Ironwood Pharmaceuticals (IRWD) stake by 92% in Q2 2026, selling an estimated $1.43M and leaving 32,991 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

Amundi first reported a position in IRWD in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.53M in Q3 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Amundi held 32,991 shares of Ironwood Pharmaceuticals worth $139K as of Q2 2026.
  • Amundi sold 371,246 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.43M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #2008 holding.
  • Amundi first reported a position in Ironwood Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Amundi's Ironwood Pharmaceuticals position peaked at $3.53M in Q3 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.